Response by Vandecasteele et al to Letter Regarding Article, "Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure"

Circulation. 2021 Jan 26;143(4):e26-e27. doi: 10.1161/CIRCULATIONAHA.120.051628. Epub 2021 Jan 25.

Authors

Grégoire Vandecasteele¹, Delphine Mika¹, Jean Piero Margaria², Alessandra Ghigo², Emilio Hirsch², Jérôme Leroy¹, Rodolphe Fischmeister¹

Affiliations

¹ Université Paris-Saclay, Inserm, UMR-S 1180, 92296, Châtenay-Malabry, France (G.V., D.M., J.L., R.F.).
² Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Italy (J.P.M., A.G., E.H.).

PMID: 33493025
DOI: 10.1161/CIRCULATIONAHA.120.051628

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic Agents*
Cyclic Nucleotide Phosphodiesterases, Type 4 / genetics
Heart
Heart Failure* / genetics
Humans

Substances

Adrenergic Agents
Cyclic Nucleotide Phosphodiesterases, Type 4
PDE4B protein, human